Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma

Kathrin A Schmohl, Patrick Dolp, Christina Schug, Kerstin Knoop, Kathrin Klutz, Nathalie Schwenk, Peter Bartenstein, Peter J Nelson, Manfred Ogris, Ernst Wagner, Christine Spitzweg

    Publications: Contribution to journalArticlePeer Reviewed

    Original languageEnglish
    Pages (from-to)1534-1543
    Number of pages10
    JournalThyroid
    Volume27
    Issue number12
    DOIs
    Publication statusPublished - Dec 2017

    Austrian Fields of Science 2012

    • 301207 Pharmaceutical chemistry

    Keywords

    • Journal Article
    • anaplastic thyroid carcinoma
    • gene therapy
    • I-131 THERAPY
    • sodium-iodide symporter (NIS)
    • TARGETED RADIOIODINE THERAPY
    • LIVER-CANCER
    • ENHANCED PERMEABILITY
    • RETINOIC ACID
    • radioiodine
    • PROSTATE-CANCER
    • GENE-THERAPY
    • EGFR targeting
    • HEPATOCELLULAR CANCER
    • SYSTEMIC NONVIRAL DELIVERY
    • EXPRESSION

    Fingerprint

    Dive into the research topics of 'Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma'. Together they form a unique fingerprint.

    Cite this